Background It is important to establish whether research recommendations regarding
magnesium sulphate for neuroprotection can be readily translated into clinical practice and …

Background Epidemiological and basic science evidence suggests that magnesium
sulphate before birth may be neuroprotective for the fetus. Objectives To assess the effects …

Key content: The prevalence of preterm birth is increasing and owing to advances in
neonatal care, more infants are surviving. However, in parallel with this, the incidence of …

Objective To evaluate whether magnesium sulphate (MgSO4) given to women at risk of very‐
preterm birth would be neuroprotective in preterm newborns and would prevent neonatal …

Premature birth increases a child's risk of cerebral palsy and death. The aim of this work is to
investigate the association between treatment with magnesium sulphate during premature …

Background Survival of preterm infants has improved drastically. In addition to significant
contribution to neonatal mortality, impact of prematurity among survivors may continue …

Objective To study the effect of antenatal magnesium sulphate (MgSO4) on cerebral palsy
(CP) in a manner that also provides adequate power for a linked trial sequential analysis …

Background The effectiveness of antenatal magnesium sulphate for neuroprotection of the
fetus, infant, and child prior to very preterm birth, when given to women considered at risk of …

The aim of our study was to assess the feasibility of implementing a protocol for the use of
magnesium sulfate to prevent cerebral palsy. This retrospective single-center study included …

Importance Intravenous magnesium sulfate administered to pregnant individuals before birth
at less than 30 weeks' gestation reduces the risk of death and cerebral palsy in their …